It can be exciting when a brand like Amazon drops new versions of its devices,

If you've ever felt that English could use a couple more tenses to truly capture the nuances of the past, present, and future, this exploration of languages that have taken verb tenses to fascinating new heights is for you.

Discord.io, a service that allowed users to create custom links for their Discord channels, is

Micron Technology Inc. promised to invest another 4.3 billion yuan ($602 million) in its Chinese chip-packaging plant, a

Amazon revealed a flood of new devices this week, ensuring that every corner of your

It turns out that human ancestors and dinosaurs could have actually co-existed, according to new research. Scientists have produced a study which suggested that placental mammals were around before the asteroid that brought an end to the Cretaceous period hit Earth 66 million years ago. A new paper published in the journal Current Biology claims that fossil records of placental mammals suggests that our ancestors roamed the Earth before the extinction event, and later flourished due to the lack of competition from dinosaur species afterwards. According to the research, primates evolved shortly before the asteroid hit. Sign up to our free Indy100 weekly newsletter Lead author Emily Carlisle of Bristol’s School of Earth Sciences said: “We pulled together thousands of fossils of placental mammals and were able to see the patterns of origination and extinction of the different groups.” Carlisle added: “Based on this, we could estimate when placental mammals evolved.” “The model we used estimates origination ages based on when lineages first appear in the fossil record and the pattern of species diversity through time for the lineage,” co-author Daniele Silvestro from the University of Fribourg shared. While we don’t have a full picture of what human ancestors looked like at that time, it’s thought they “were small and squirrely”. Carlisle said: “Unfortunately we don’t know what our placental mammal ancestors would have looked like back then. “Many of the earliest fossils of placental mammals are quite small creatures such as Purgatorius – an early ancestor of primates – which was a small burrowing creature a bit like a tree shrew. So it’s likely that many of our ancestors were small and squirrely.” Have your say in our news democracy. Click the upvote icon at the top of the page to help raise this article through the indy100 rankings.

TL;DR: A lifetime subscription to Microsoft Office is on sale for under £25. Software subscriptions

Days after Apple unveiled its $3,499 mixed reality headset, Meta CEO Mark Zuckerberg appeared to take a jab at the company's pricing and vision for the product.

NEW YORK The U.S. Securities and Exchange Commission on Tuesday sued Virtu Financial, accusing the large market maker

If you're looking to donate money to help those affected by the wildfires in Hawaii -- or looking to support any charitable cause close to your heart — it's important to follow certain steps to ensure your money is going to the right place.

Some of the world’s biggest tech companies, including Dell Technologies Inc., HP Inc. and Apple Inc. supplier Foxconn

Our canine companions could soon be enjoying much longer lifespans, if a drug which claims it can extend dogs’ lives eventually gets approved. The drug, made by a tech firm in California, just cleared a vital hurdle to doing just that, after it got partial approval by regulators in the US. Loyal, a San Francisco-based company founded in 2020, has been researching how it can increase dogs’ lifespans – in particular larger breeds, which tend to die younger. Large and “giant” breeds tend to live to between eight and 12 years. Smaller dogs, such as Chihuahuas, can keep going to the ripe old age of 20. Loyal’s main product, the catchily-titled LOY-001, is designed not only to extend dogs’ lives but also maintain their quality of life. Now, it has passed the “reasonable expectation of effectiveness” test, set by regulators at the US’ Food and Drug Administration. Loyal’s chief executive, Celine Halioua, said: "Loyal was founded with the ambitious goal of developing the first drugs to extend healthy lifespan in dogs. "This milestone is the result of years of careful work by the team. We'll continue to work just as diligently to bring this and our other longevity programs through to FDA approval." Selective breeding of dogs has caused higher levels of hormones which help the animals grow faster. That is also believed to reduce their lifespan, the company said. Big dogs tend to have more of this hormone than their smaller counterparts. Animal rights activists are not yet convinced. Some experts fear it will only serve to extend animals’ suffering. Loyal, on the other hand, says the drug aims to treat doggy diseases which are associated with ageing through preventing them, rather than waiting for the animals to get sick before treating them. The company said that the drug could be available to US customers as early as 2026. So that’s plenty of time for walkies between now and then. How to join the indy100's free WhatsApp channel Sign up to our free indy100 weekly newsletter Have your say in our news democracy. Click the upvote icon at the top of the page to help raise this article through the indy100 rankings.